Back

Risk prediction models for incident heart failure: a systematic review and meta-analysis

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Models to predict unfavourable outcomes in heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Jose Miguel Navarro

Toronto (Canada)

8 More presentations in this session

Presentation thumbnail
A flexible, calibrated transformer-based risk model for prediction of clinical outcomes in patients with heart failure; an open cohort study using linked UK EHR
Doctor S. Rao (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Prognostic value of reticulocyte production ability in patients with chronic heart failure
Doctor M. Nakao (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Explainable machine learning and multi-modal data for predicting readmission in patients with heart failure
Ms R. Chae (US)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of genotype findings in non-ischemic dilated cardiomyopathy: a network meta-analysis
Doctor V. Anastasiou (London, GB)
Abstract Slides Video
Presentation thumbnail
Development and validation of a predicting model for risk of mortality in heart failure patients with mildly reduced ejection fraction post discharge
Professor Y. Zhu (Xiangtan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Models to predict unfavourable outcomes in heart failure

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Prediction of incident heart failure in the community: systematic review, meta-analysis, modelling study, and pilot implementation
thumbnail
Congress Presentation
Three rules to find them all: clinical risk scores in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Cancer-specific Heart Failure (HF) risk score - a new risk score developed specifically to predict HF among cancer survivors

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources